Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Dose-Dependent Iron Chelating Effects of Eltrombopag on in Vitro Human Megakaryopoiesis

Zhi-Jian Liu, PhD, Emoke Deschmann, MD, Haley E. Ramsey, PhDMSc, Henry Feldman, Bethan Psaila, MD PhD, Nichola Cooper, MD MRCP, Evangelia Vlachodimtropoulou Koumoutsea, MBBS,PhDBSc, John B. Porter, MA MDFRCP FRCPath, James B. Bussel, MD, Michael Georgieff, MD, Martha Sola-Visner, MD

Blood (2019) 134 (Supplement_1): 2475.

https://doi.org/10.1182/blood-2019-131895

Published: 2019

Journal Articles

Is Hemophilia B Clinically Less Severe Than Hemophilia a? Evidence from the Hugs Va and Vb Studies

Megan M. Ullman, MA, MPH, Randall Curtis, MBA, Mimi Lou, MS, Brenda Riske, MBA, MS, Judith Baker, DrPH, MHSA, Duc Quang Tran, Jr., MD, Joanne Wu, Michael B. Nichol, PhD

Blood (2019) 134 (Supplement_1): 58.

https://doi.org/10.1182/blood-2019-129439

Published: 2019

Journal Articles

Chitinase 3-like 1 Produced By Fibrocytes Promotes Myelofibrosis

Blood (2019) 134 (Supplement_1): 4197.

https://doi.org/10.1182/blood-2019-125525

Published: 2019

Journal Articles

Influence of Age on Treatment with Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia; A Retrospective Multicenter Study

Blood (2019) 134 (Supplement_1): 2361.

https://doi.org/10.1182/blood-2019-122237

Published: 2019

Journal Articles

Predictive Factors for Thrombopoietin Receptor Agonist Free Responses in Chronic ITP Patients: A Multicenter Retrospective Study with Long-Term Follow-up

Blood (2019) 134 (Supplement_1): 2370.

https://doi.org/10.1182/blood-2019-125580

Published: 2019

Journal Articles

Angioimmunoblastic T-Cell Lymphoma: Molecular Characterization of Clonal T and B-Cells and a Patient Derived Xenograft Model of Coexisting T and B-Cell Proliferations

Xiaoxian Zhao, PhD, Bartlomiej Przychodzen, Juraj Bodo, PhD, Lisa Durkin, Daniel Lindner, MD PhD, Neetha Parameswaran, PhD, Michael Clemente, MS, Sarah L. Ondrejka, DO, Jaroslaw P. Maciejewski, MD PhD, Deepa Jagadeesh, MDMPH, Eric D. Hsi, MD

Blood (2019) 134 (Supplement_1): 1572.

https://doi.org/10.1182/blood-2019-129131

Published: 2019

Journal Articles

Increased SLAMF7 high monocytes in myelofibrosis patients harboring JAK2 V617F provide a therapeutic target of elotuzumab

Blood (2019) 134 (10): 814–825.

https://doi.org/10.1182/blood.2019000051

Published: 2019

Includes: Supplemental data

Journal Articles

The Transition from Childhood to Adulthood in Chronic Immune Thrombocytopenia Patients: Clinical Management and the Role of Splenectomy and Thrombopoietin Receptor Agonists in a Single Center Experience

Monica Carpenedo, MD, Marco Spinelli, MD, Sara Pezzatti, MD, Momcilo Jancovic, MD, Rossella Renso, MD, Andrea Biondi, Carlo Gambacorti-Passerini, MD

Blood (2018) 132 (Supplement 1): 4987.

https://doi.org/10.1182/blood-2018-99-114050

Published: 2018

Journal Articles

Bilateral, Simultaneous Total Knee Replacement (TKR) Surgery for Hemophilia a with Eloctate (Extended Half Life Product)—A Feasible and Cost Effective Approach

Shashikant Apte, MD FRCPA, Rajesh Phatale, MD, Aditi Joshi, BAMS, Kannan Subramanian, MD DM, MBBS

Blood (2018) 132 (Supplement 1): 4684.

https://doi.org/10.1182/blood-2018-99-116160

Published: 2018

Journal Articles

A Canadian Cost-Effectiveness Analysis for the Treatment of Immune Thrombocytopenia: Assessing the Relative Value of with Eltrombopag Versus Romiplostim

Gabriel Tremblay, DBA, MSc, BS, Mike Dolph, MSc BHSc, Anuja Roy, PhD, Juliette Neyra, PharmD, Khalid El Ouagari, Anna Forsythe, PharmD, MSc, MBA

Blood (2017) 130 (Supplement 1): 3410.

https://doi.org/10.1182/blood.V130.Suppl_1.3410.3410

Published: 2017

Journal Articles

Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study

Chatree Chai-Adisaksopha, MD, Mark Skinner, Randall Curtis, MBA, Neil Frick, Michael B. Nichol, PhD, Declan Noone, Brian O'Mahony, David Page, Jeffrey Stonebraker, Alfonso Iorio, MD PhD

Blood (2017) 130 (Supplement 1): 2141.

https://doi.org/10.1182/blood.V130.Suppl_1.2141.2141

Published: 2017

Journal Articles

A Large Cohort Comparison of 2005 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria to 2014 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria

Blood (2017) 130 (Supplement 1): 4720.

https://doi.org/10.1182/blood.V130.Suppl_1.4720.4720

Published: 2017

Journal Articles

Health-Related Quality of Life and Health Insurance Coverage Among Persons with Hemophilia A Inhibitors

Michael B. Nichol, PhD, Ning Ning, MS, Yaping Xu, Judith Baker, DrPH, MHSA, Randall Curtis, MBA, Marion A. Koerper, MD, Mimi Lou, MS, Brenda Riske, MBA, MS, Megan Ullman, MA, MPH, Joanne Wu, MD MS

Blood (2017) 130 (Supplement 1): 4736.

https://doi.org/10.1182/blood.V130.Suppl_1.4736.4736

Published: 2017

Journal Articles

Immunomodulatory Effects of HDACi in Combination with Checkpoint Blockade and Lenalidomide in the Immunosuppressive Multiple Myeloma Bone Marrow Microenvironment

Greg D Whitehill, BS, Alicia Chivers, MS, Bryan Danielson, PhD, Julien SR Tessier, MS, Gabriela Hernandez Duran, Gabrielle L Bender, BS, Douglas W. Sborov, MD MSc, Craig C Hofmeister, MDMPH, James Bradner, MD, Teru Hideshima, MD PhD, Kenneth C Anderson, MD, Gullu Gorgun, PhD

Blood (2017) 130 (Supplement 1): 4422.

https://doi.org/10.1182/blood.V130.Suppl_1.4422.4422

Published: 2017

Journal Articles

Safety and Clinical Activity of Combined Romidepsin and Azacitidine Therapy in High Risk Acute Myeloid Leukemia: Preliminary Results of the Romaza Trial

Charles Craddock, Eleni Tholouli, MD PhD, Samuel Munoz Vicente, MSc, Emmanouela Gbandi, BSc, MSc, MScM, PhD, Aimee E Houlton, BSc, MSc, Mark W Drummond, MB ChB, PhD FRCPath, Jiri Pavlu, MD, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath

Blood (2017) 130 (Supplement 1): 2581.

https://doi.org/10.1182/blood.V130.Suppl_1.2581.2581

Published: 2017

Journal Articles

The Relationship of Joint Range of Motion to Factor Activity in Patients with Hemophilia A and B without Prophylaxis: A Longitudinal Assessment of the CDC-UDC Hemophilia Dataset

Michael Wang, MD, Michael Recht, Neeraj Iyer, PhD, David L Cooper, MD, John Michael Soucie, PhD

Blood (2017) 130 (Supplement 1): 756.

https://doi.org/10.1182/blood.V130.Suppl_1.756.756

Published: 2017

Journal Articles

Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project

Marilyn J. Manco-Johnson, J. Michael Soucie, Joan Cox Gill

Blood (2017) 129 (17): 2368–2374.

https://doi.org/10.1182/blood-2016-02-683169

Published: 2017

Journal Articles

"Hemophilia Vertical": Effects of Therapeutic Rock Climbing on Joint Health in Hemophilia Patients with Severe Arthropathies

Courtney Schroeder, Felix Kallenbach, Lena Volland, Richard FW Barnes, Colleen M Moran, Christine Geyer, Regina von Velsen, Annette von Drygalski, MD PharmD, Michaela Andrea Stemberger

Blood (2016) 128 (22): 4754.

https://doi.org/10.1182/blood.V128.22.4754.4754

Published: 2016

Journal Articles

Pathological Heterotopic Ossifications in Brain or Spinal Cord Injured Patients: From Ectopic Bone to Hematopoietic Stem Cell Niche Development

Frédéric Torossian, PhD, Bernadette Guerton, Adrienne Anginot, PhD, Nassim Arouche, Laetitia Boutin, Denis Clay, Nathalie Rochet, PhD MD, Christophe Desterke, PhD, Erica Vlachos, Guillaume Genet, Philippe Denormandie, PhD MD, François Genet, PhD MD, Jean-Pierre Levesque, PhD, Jean-Jacques Lataillade, PhD MD, Marie-Caroline Le Bousse-Kerdiles, PhD

Blood (2016) 128 (22): 3889.

https://doi.org/10.1182/blood.V128.22.3889.3889

Published: 2016

Journal Articles

Final Results of a Randomized Phase 2 Trial Evaluating Lower-Dose Versus Higher-Dose Pomalidomide as Therapy for Corticosteroid-Refractory Chronic Gvhd

Lauren M. Curtis, MD, David Venzon, PhD, Fran T. Hakim, PhD, Edward W. Cowen, MD MHSc, Jennifer Hsu, RN, Licia Masuch, Jacqueline W. Mays, DDS, MHSc, PhD, Sandra A. Mitchell, CRNP, PhD AOCN, Filip Pirsl, Iskra Pusic, MD, Jeremy J. Rose, MS, Zoya J. Kuzmina, MD PhD, Kristin Baird, MD, Robert Peter Gale, Daniel H. Fowler, MD, Ronald E. Gress, MD, Steven Z. Pavletic, MD

Blood (2016) 128 (22): 507.

https://doi.org/10.1182/blood.V128.22.507.507

Published: 2016

NARROW

Dose-Dependent Iron Chelating Effects of Eltrombopag on in Vitro Human Megakaryopoiesis

Is Hemophilia B Clinically Less Severe Than Hemophilia a? Evidence from the Hugs Va and Vb Studies

Chitinase 3-like 1 Produced By Fibrocytes Promotes Myelofibrosis

Influence of Age on Treatment with Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia; A Retrospective Multicenter Study

Predictive Factors for Thrombopoietin Receptor Agonist Free Responses in Chronic ITP Patients: A Multicenter Retrospective Study with Long-Term Follow-up

Angioimmunoblastic T-Cell Lymphoma: Molecular Characterization of Clonal T and B-Cells and a Patient Derived Xenograft Model of Coexisting T and B-Cell Proliferations

Increased SLAMF7 high monocytes in myelofibrosis patients harboring JAK2 V617F provide a therapeutic target of elotuzumab

The Transition from Childhood to Adulthood in Chronic Immune Thrombocytopenia Patients: Clinical Management and the Role of Splenectomy and Thrombopoietin Receptor Agonists in a Single Center Experience

Bilateral, Simultaneous Total Knee Replacement (TKR) Surgery for Hemophilia a with Eloctate (Extended Half Life Product)—A Feasible and Cost Effective Approach

A Canadian Cost-Effectiveness Analysis for the Treatment of Immune Thrombocytopenia: Assessing the Relative Value of with Eltrombopag Versus Romiplostim

Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study

A Large Cohort Comparison of 2005 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria to 2014 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria

Health-Related Quality of Life and Health Insurance Coverage Among Persons with Hemophilia A Inhibitors

Immunomodulatory Effects of HDACi in Combination with Checkpoint Blockade and Lenalidomide in the Immunosuppressive Multiple Myeloma Bone Marrow Microenvironment

Safety and Clinical Activity of Combined Romidepsin and Azacitidine Therapy in High Risk Acute Myeloid Leukemia: Preliminary Results of the Romaza Trial

The Relationship of Joint Range of Motion to Factor Activity in Patients with Hemophilia A and B without Prophylaxis: A Longitudinal Assessment of the CDC-UDC Hemophilia Dataset

Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project

"Hemophilia Vertical": Effects of Therapeutic Rock Climbing on Joint Health in Hemophilia Patients with Severe Arthropathies

Pathological Heterotopic Ossifications in Brain or Spinal Cord Injured Patients: From Ectopic Bone to Hematopoietic Stem Cell Niche Development

Final Results of a Randomized Phase 2 Trial Evaluating Lower-Dose Versus Higher-Dose Pomalidomide as Therapy for Corticosteroid-Refractory Chronic Gvhd

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only